5-alpha Reductase

Sigaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S1202 Dutasteride <1 mg/mL 62 mg/mL 6 mg/mL
S1197 Finasteride <1 mg/mL 75 mg/mL 75 mg/mL
S4593 Chlormadinone acetate <1 mg/mL 27 mg/mL 1 mg/mL
Catalog No. Information Product Use Citations Product Validations
S1202

Dutasteride

Dutasteride is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT).

S1197

Finasteride

Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).

S4593New

Chlormadinone acetate

Chlormadinone acetate is a steroidal progestin with additional antiandrogen and antigonadotropic effects, used often in combinations as an oral contraceptive. Its half-life is about 34-38 hours.

Catalog No. Information Product Use Citations Product Validations
S1202

Dutasteride

Dutasteride is a dual 5-α reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone (DHT).

S1197

Finasteride

Finasteride is a potent, reversible inhibitor of the rat type 1 5 alpha-reductase with Ki of 10.2 nM, used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness (MPB).

Catalog No. Information Product Use Citations Product Validations
S4593New

Chlormadinone acetate

Chlormadinone acetate is a steroidal progestin with additional antiandrogen and antigonadotropic effects, used often in combinations as an oral contraceptive. Its half-life is about 34-38 hours.

Tags: 5-alpha reductase inhibition | 5-alpha reductase deficiency | 5-alpha reductase enzyme | 5-alpha reductase syndrome | 5-alpha reductase activity | 5-alpha reductase treatment | 5-alpha reductase drugs | 5-alpha reductase assay | 5-alpha reductase pseudohermaphrodites | 5-alpha reductase inhibitor drugs | 5-alpha reductase inhibitor prostate cancer | 5-alpha reductase pathway | 5-alpha reductase inhibitor review